NYLIM
HLVX

New York Life Investment Management’s HilleVax HLVX Stock Holding History

New York Life Investment Management’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-22,512
Closed -$374K – 1065
2024
Q1 		$374K Buy
+22,512
New +$360K ﹤0.01% 898

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CP
Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return

New York Life Investment Management's HLVX Position: Q2 2024 in Review

New York Life Investment Management sold out of HilleVax (HLVX) in Q2 2024, closing a stake of 22,512 shares — an estimated $374K sold.

New York Life Investment Management first reported a position in HLVX in Q1 2024 and held it in 1 quarter. The position peaked at $374K in Q1 2024. 93 funds tracked by Wall St. Rank hold HLVX as of Q2 2024.

  • New York Life Investment Management reported no remaining HilleVax position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 22,512 HilleVax shares in Q2 2024, an estimated $374K.
  • New York Life Investment Management first reported a position in HilleVax in Q1 2024 and held it in 1 quarter.
  • New York Life Investment Management's HilleVax position peaked at $374K in Q1 2024.
  • 93 funds tracked by Wall St. Rank held HilleVax as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.